A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 620 participants.
Also called NCT06991257
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 620 participants
- Sponsor
- Registry
-
NCT06991257 -
2024-518438-94-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Brazil, Bulgaria, Canada, China, Czechia, France, Hungary, Japan, Poland, Puerto Rico, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06991257. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-19 (actual); primary completion 2028-05-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Condition
- Heart Failure
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Low Dose PF-07328948
- Intervention (Drug)
- Medium Dose PF-07328948
- Intervention (Drug)
- High Dose PF-07328948
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct06991257- Content hash
cccf48bd73e769e4831604c3f5b494198f29653fa6e74aba4c3c3bb032bcefd7